Search

for
Search:

GlossaryDocetaxel

chemotherapy drug that inhibits cancer cell division

Docetaxel, also known by the brand name Taxotere, is a chemotherapy medication used to treat various types of cancer, including breast, lung, prostate, and stomach cancers. It works by inhibiting cell division, which helps to stop the growth and spread of cancer cells.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 313 results

research Docetaxel

400 citations, October 1995 in “Journal of clinical oncology”

Docetaxel is effective against various cancers but mainly causes neutropenia.

Docetaxel, Cisplatin and 5-Fluorouracil in Patients with Locally Advanced Unresectable Head and Neck Cancer: A Phase I-II Feasibility Study

research Docetaxel, Cisplatin and 5-Fluorouracil in Patients with Locally Advanced Unresectable Head and Neck Cancer: A Phase I-II Feasibility Study

78 citations, March 2004 in “Annals of Oncology”

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

research Irreversible And Severe Alopecia Following Docetaxel Or Paclitaxel Cytotoxic Therapy For Breast Cancer

61 citations, April 2009 in “British journal of dermatology/British journal of dermatology, Supplement”

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

research Efficacy and Tolerability of Two Scalp Cooling Systems for the Prevention of Alopecia Associated with Docetaxel Treatment

52 citations, May 2013 in “Supportive Care in Cancer”

Scalp cooling significantly reduces hair loss in chemotherapy patients.

Weekly Docetaxel in Minimally Pretreated Cancer Patients: A Dose-Escalation Study Focused on Feasibility and Cumulative Toxicity of Long-Term Administration

research Weekly Docetaxel in Minimally Pretreated Cancer Patients: A Dose-Escalation Study Focused on Feasibility and Cumulative Toxicity of Long-Term Administration

50 citations, June 1999 in “Annals of Oncology”

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

View more "docetaxel" in research →

Community Join

0 / 0 results

— no results